Since ADMA acts on vascular function by inhibiting eNOS, it is feasible to suggest that higher ADMA levels would inhibit NO production, resulting in vasoconstriction, hypertension, immune dysfunction and ultimate endothelial dysfunction in CKD [29]. Here, NOS3 is linked to chronic kidney disease.